Therasense Stock Earnings Per Share
| THER Stock | USD 0.0001 0.00 0.00% |
Therasense fundamentals help investors to digest information that contributes to Therasense's financial success or failures. It also enables traders to predict the movement of Therasense Pink Sheet. The fundamental analysis module provides a way to measure Therasense's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Therasense pink sheet.
Therasense |
Therasense Company Earnings Per Share Analysis
Therasense's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Therasense Earnings Per Share | (0) X |
Most of Therasense's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Therasense is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Therasense has an Earnings Per Share of -0.001 times. This is 100.01% lower than that of the Healthcare sector and 99.98% lower than that of the Biotechnology industry. The earnings per share for all United States stocks is 100.03% higher than that of the company.
Therasense Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Therasense's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Therasense could also be used in its relative valuation, which is a method of valuing Therasense by comparing valuation metrics of similar companies.Therasense is currently under evaluation in earnings per share category among its peers.
Therasense Fundamentals
| Return On Asset | -169.9 | |||
| Current Valuation | 27.3 M | |||
| Shares Outstanding | 6.15 B | |||
| Shares Owned By Insiders | 83.61 % | |||
| Number Of Shares Shorted | 199.92 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 57.46 X | |||
| Revenue | 353.26 K | |||
| Gross Profit | 256.68 K | |||
| EBITDA | (5.53 M) | |||
| Net Income | (7.75 M) | |||
| Cash And Equivalents | 127.82 K | |||
| Total Debt | 2.9 M | |||
| Current Ratio | 0.22 X | |||
| Cash Flow From Operations | (5.54 M) | |||
| Short Ratio | 2.60 X | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 16 | |||
| Beta | 22.12 | |||
| Market Capitalization | 20.3 M | |||
| Total Asset | 52 M | |||
| Retained Earnings | (248.68 M) | |||
| Working Capital | 6.84 M | |||
| Current Asset | 18.12 M | |||
| Current Liabilities | 11.29 M | |||
| Z Score | -1.4 |
About Therasense Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Therasense's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Therasense using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Therasense based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.